• Citer

Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases.

par Yanni, Antoine ;Bouland, Cyril ;Monteiro, Ana Raquel;Rodriguez, Alexandra;Loeb, Isabelle ;Javadian, Rokneddine;Dequanter, Didier
Référence Journal of International Society of Preventive and Community Dentistry, 12, 5, page (564-570)
Publication Publié, 2022-01-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases.
Auteur:	Yanni, Antoine; Bouland, Cyril; Monteiro, Ana Raquel; Rodriguez, Alexandra; Loeb, Isabelle; Javadian, Rokneddine; Dequanter, Didier
Informations sur la publication:	Journal of International Society of Preventive and Community Dentistry, 12, 5, page (564-570)
Statut de publication:	Publié, 2022-01-01
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Antiresorptive and antiangiogenic agents
	osteonecrosis of the jaw
	risk factors
	treatment
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2231-0762
	info:doi/10.4103/jispcd.JISPCD_110_22
	info:pii/JISPCD-12-564
	info:scp/85144779940
	info:pmid/36532328
	PMC9753918